Ligand Pharmaceuticals LGND
NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Work In Process (2023 - 2024)

Updated

Ligand Pharmaceuticals (LGND) recorded Work In Process of $3.92 million in Q4 2024, compared with $195,000 a year earlier.

Analysis

Ligand Pharmaceuticals (LGND) Work In Process (2023 - 2024) Analysis & Trends

Starting with Q4 2023, Ligand Pharmaceuticals' Work In Process history includes 4 quarters.

  • Across earlier years, Work In Process came in at $195,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.92 Mn
Sep 30, 2024 260,000.00
Jun 30, 2024 548,000.00
Dec 31, 2023 195,000.00
API Access

Ligand Pharmaceuticals Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=LGND&period=max&api_key=YOUR_API_KEY